drug

Dangerous "Off-Label" Prescribing Illegally Marketed By Drug Companies

Monday, February 23, 2009 by: David Gutierrez, staff writer
Tags: off-label prescribing, health news, Natural News

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
BACK INTO THE CLOSET: Why U.S. reporters are not allowed to write about rainbow events in nations where being gay is still condemned
Depopulation test run? 75% of children who received vaccines in Mexican town now dead or hospitalized
A family destroyed: Six-month-old dies after clinic injects baby with 13 vaccines at once without mother's informed consent
Biologist explains how marijuana causes tumor cells to commit suicide
INVESTIGATION: Three days before Dr. Bradstreet was found dead in a river, U.S. govt. agents raided his research facility to seize a breakthrough cancer treatment called GcMAF
Companies begin planting microchips under employees' skin
BAM! Chipotle goes 100% non-GMO; flatly rejecting the biotech industry and its toxic food ingredients
ECONOMIC SLAVERY FOR ALL: While we were distracted with the Confederate flag flap, Congress quietly forfeited our entire economic future via fast-track trade authority
NJ cops bust teenagers shoveling snow without a permit
Chemotherapy kills cancer patients faster than no treatment at all
McDonald's in global profit free fall as people everywhere increasingly reject chemically-altered toxic fast food
March Against Monsanto explodes globally... World citizens stage massive protests across 38 countries, 428 cities... mainstream media pretends it never happened
Italian court rules mercury and aluminum in vaccines cause autism: US media continues total blackout of medical truth
SCOTUS same-sex marriage decision may have just legalized the concealed carry of loaded firearms across all 50 states, nullifying gun laws everywhere
Orthorexia Nervosa - New mental disorder aimed at people who insist on eating a clean diet
Vicious attack on Dr. Oz actually waged by biotech mafia; plot to destroy Oz launched after episode on glyphosate toxicity went viral
Nearly every mass shooting in the last 20 years shares one surprising thing? and it's not guns
Holistic cancer treatment pioneer Dr. Nicholas Gonzalez dies suddenly; patients mourn the loss of a compassionate, innovative doctor who helped thousands heal from cancer
Delicious
(NaturalNews) The FDA has little ability to police illegal marketing of drugs for unapproved uses, a report from the federal Government Accountability Office (GAO) has warned. This means that an illegal and potentially dangerous practice that is believed to be widespread is going essentially unregulated.

"[The FDA] isn't keeping track of how drugs are marketed for off-label use, even though marketing for off-label use is illegal and it's the FDA's job to enforce that law," said Sen. Charles Grassley, who commissioned the report. "As a result, drug makers aren't being held accountable for promoting unapproved use of medicine, and patient safety is diminished."

Federal law prohibits pharmaceutical companies from marketing a drug to either consumers or doctors for a use that has not been specifically approved by the FDA - also known as an "off label" use. This is because FDA approval of a drug use requires the completion of certain clinical trials; off-label uses have not been subject to this process, and there is no way to know if the drug actually works to treat the condition for which it is being prescribed.

In some cases, off-label uses may indeed help patients. But in other cases, they may actually cause harmful effects, or at best waste a patient's money.

Yet federal law also allows doctors to make the ultimate decisions on which drugs to prescribe, and therefore allows off-label prescriptions.

Yet a 2006 study suggests that more than 20 percent of all prescriptions written in the United States are for non-approved drug uses. And off-label prescribing can vastly increase the profits for pharmaceutical companies such as Cephalon, which saw surging profits once off-label prescribing of its narcolepsy drug Provigil took off for Alzheimer's disease, attention deficit disorder, cocaine addiction, depression, general fatigue and jet lag.

Drug companies have actively lobbied for more relaxed rules regarding off-label marketing. In response, the FDA has proposed new rules that would allow companies to provide doctors with scientific information concerning potential off-label uses.

Even so, Grassley and other pharmaceutical industry critics believe that overtly illegal marketing of drugs for off-label uses remains widespread.

Fear of legal consequences is unlikely to deter the practice. According to the GAO report, the FDA is simply not equipped to police off-label marketing practices, even the most blatant. Off-label marketing rules are monitored by the Division of Drug Marketing, Advertising and Communications (DDMAC), the same division that monitors all television, magazine and other drug marketing - approximately 68,000 ads in 2007. With only 44 full-time employees, DDMAC receives "substantially more materials than the agency can review," the report says.

Once the FDA has detected an instance of illegal off-label marketing, it takes an average of seven months for it to issue a warning letter, the GAO found, with an average of four more months before the company actually changes its behavior. In one case, it took 17 months for Reliant Pharmaceuticals to issue new promotional material after receiving a warning letter.

The FDA issued 42 warning letters over possible illegal off-label marketing practices from 2003 to 2007, all of which were resolved without calling on the Justice Department. In addition, 11 lawsuits were settled in that time period over off-label marketing by drug companies.

According to the GAO report, it is not just a lack of staff but a failure of organization that hampers the FDA's ability to enforce off-label marketing laws.

"FDA does not prioritize its reviews in a systematic manner, but rather relies on its staff to sort through large volumes of material and select submissions for review," the report reads. "FDA is also hampered by the lack of a system that consistently tracks the receipt and review of submitted materials. To address these shortcomings, GAO recommended in 2006 that FDA track which materials it has reviewed. FDA has not acted on this recommendation."

Sources for this story include: ap.google.com; www.mmm-online.com; www.honionline.com; www.gao.gov.

Follow real-time breaking news headlines on
Off-label prescribing at FETCH.news
Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.